AGIO:NASDAQ
Agios Pharmaceuticals Inc
$31.19
arrow_downward
-1.27%(-0.40) 1D
Nov 16, 11:56:15 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
$31.29
High
$31.70
Low
$30.91
Mkt. cap
1.87B
Avg. vol.
1.24M
Volume
80.15K
52-wk high
$45.99
52-wk low
$22.24
EPS
-$6.32
Beta
0.66
Shares outstanding
59.81M
No. of employees
540
Open
$31.29
High
$31.70
Low
$30.91
Mkt. cap
1.87B
Avg. vol.
1.24M
Volume
80.15K
52-wk high
$45.99
52-wk low
$22.24
EPS
-$6.32
Beta
0.66
Shares outstanding
59.81M
No. of employees
540
News stories
From web sources and news partners
Benzinga
·
57 minutes ago
Here’s How Much You Would Have Made Owning iShares S&P 500 Growth ETF Stock In The Last 15 Years
Benzinga
·
8 minutes ago
Forget Nvidia — S&P 500's 8,900 Target Puts These ETFs in Play - State Street SPDR S&P 500 ETF Trust (ARC
BigGo Finance
·
2 hours ago
Bitget Opens Onchain Yield Vaults for Tokenized S&P 500, Nasdaq-100 Trackers
Traders Union
·
1 hour ago
Peter Tuchman: S&P 500 loses over $800 billion in market cap
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc